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Abstract
Background: The mammalian heme peroxidases (MHPs) are a medically important
group of enzymes. Included in this group are myeloperoxidase, eosinophil peroxidase,
lactoperoxidase, and thyroid peroxidase. These enzymes are associated with such diverse
diseases as asthma, Alzheimer’s disease and inflammatory vascular disease. Despite
much effort to elucidate a clearer understanding of the function of the 4 major groups of
this multigene family, we still do not have a clear understanding of their relationships to
each other.
Results: Sufficient signal exists for the resolution of the evolutionary relationships of
this family of enzymes. We demonstrate, using a root mean squared deviation statistic,
how the removal of the fastest evolving sites aids in the minimisation of the effect of
long branch attraction and the generation of a highly supported phylogeny. Based on this
phylogeny we have pinpointed the amino acid positions that have most likely contributed
to the diverse functions of these enzymes. Many of these residues are in close proximity
to sites implicated in protein misfolding, loss of function or disease.
Conclusion: Our analysis of all available genomic sequence data for the MHPs from all
available completed mammalian genomes, involved sophisticated methods of phylogeny
reconstruction and data treatment. Our study has (i) fully resolved the phylogeny of the
MHPs and the subsequent pattern of gene duplication, and (ii), we have detected amino
acids under positive selection that have most likely contributed to the observed
functional shifts in each type of MHP.
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Background:
Heme peroxidases are readily abundant enzymes that can be classified into two major
families, namely the animal and non-animal peroxidases, that have arisen from two
independent evolutionary events [1]. The non-animal peroxidases include plant,
bacterial, fungal and protist [1]. The classical peroxidase cycle involves the reaction
sequence from native enzyme through compound I, then compound II and finally back to
native enzyme [2]. An alternative and highly important pathway that mammalian heme
peroxidases (MHPs) pass through, depending on substrate availability, is the
halogenation cycle [3]. In the presence of H2O2 and a halide (especially iodide),
myeloperoxidase (MPO) can catalyse a halogenation reaction that plays an important
role in the antibacterial activity of leukocytes [4]. Animal peroxidases are a medically
important group of enzymes implicated in many different diseases including asthma [5],
Alzheimer’s disease (AD) [6] and inflammatory vascular disease [7]. From biochemical
studies it is believed that the heme peroxidases for mammals arose following a number
of gene duplication events [3] [8] [9].
Gene duplication provides the raw material for evolution of diversity and is believed to
be the principal source of new genes [10]. The process of gene duplication has a number
of alternative outcomes, and remains a controversial issue. Gene duplicates may become
functionally redundant [11], or functionally divergent. There are a number of ways in
which functional redundant duplicates can be preserved [12] [13]. It has been proposed
that the preservation of duplicates can be brought about by degenerative mutations in the
regulatory elements of the duplicates, this is referred to as the Duplication-Degeneration-
Complementation model (DDC) [13]. The DDC model does not allow a role for positive
selection in the evolution of duplicates and is based solely on a neutral model with
degenerate mutations and subsequent negative selection. Under this model duplicates are
preserved as each accumulates degenerate mutations, resulting in specific subfunctions
that in toto ensure optimal fitness [13].
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An alternative mode of duplicate retention is positive selection. For example, in direct
contrast to the predictions of the DDC model it has been shown for human and mouse
that the number of retentions and losses of duplicates fits more consistently with a model
incorporating positive selection [14]. Rapid divergence in gene expression profiles of
duplicates following the duplication event results in expression profiles as diverse as
those of singletons. An example of this is the functional redundancy of transcription
factor inhibitors, Iκα and β, that have acquired different functions through divergence of
gene expression rather than biochemical function [15]. Recent studies have indicated that
for mammalian genomes neofunctionalisation, be it independent of -, or coupled with -
subfunctionalisation, is the most common mode of evolution of gene duplicates [16].
These selective pressures following the process of gene duplication are key to the
evolution of specificity of divergent multigene families, such as the MHPs [17].
In those cases where having all duplicates is deleterious, dosage requirements may cause
the partitioning of subfunctions to be favored by positive selection resulting from
selective pressure for the fixation of nonfunctional or subfunctional alleles. The
divergence of function may occur through neofunctionalisation [18], or,
subfunctionalisation where the ancestral function is partitioned between the duplicates
[19] (for detail on current gene duplication models see [20]).
We hypothesise that the selective pressures on MHPs following gene duplication events
will, (i) still be traceable in the extant sequences of these enzymes, and (ii), will have
contributed to the functional diversity observed in these enzymes. A fully resolved
phylogeny can provide a basis for such comparative genomic analysis of these heme
peroxidases.
MHPs have been classified into four main families based on their function;
myeloperoxidase (MPO), eosinophil peroxidase (EPO), lactoperoxidase (LPO) and
thyroid peroxidase (TPO). MPO, EPO and LPO function in antimicrobial and innate
immune responses [21] [22] [23], whereas, TPO plays a key role in thyroid hormone
biosynthesis [24], see Table 1. A study of the structure-function relationships of human
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heme peroxidases suggest that the evolution of TPO succeeded that of MPO, EPO and
LPO, but that these families shared a common ancestor [3] [8] [9]. MHPs are present in
various tissues and as such their peroxidase function varies depending on tissue of
expression. There are both structural and functional similarities among this multigene
family of enzymes particularly with respect to their catalytic domains, this reflects their
evolutionary relatedness. It has been shown that active site residues are conserved in all
heme peroxidases [3] [25].
To infer the phylogeny of the MHPs from sequence data, it is fundamental to consider
the challenges associated with resolving mammalian gene phylogenies. The main pitfalls
include poor phylogenetic signal resulting from mutationally saturated positions,
inadequate modelling of the evolutionary process and systematic bias due to variable
rates of evolution among species or within sequences [26].
A systematic bias or systematic error is one that results in greater support for an incorrect
conclusion with the accumulation of more data. Long branch attraction (LBA) is one of
the most commonly occurring systematic biases and is a consequence of unequal
evolutionary rates across lineages. This can occur due to the number of cell divisions per
unit time being different in different species or due to rapid fixation of mutations due to
reduced population size, e.g., a bottleneck. Rodent species accumulate many more
mutations within a defined time frame than larger mammals [27] [28]. Therefore,
rodentia are often placed close to the outgroup species on a phylogeny due to their
increased number of mutations. There are a number of ways in which the noise (LBA)
can be minimised. Firstly, the addition of more taxa to the dataset: denser sampling of
species of intermediate generation time can reduce the effect of LBA by reducing the
overall distances between taxa. Secondly, the use of improved models of sequence
evolution, i.e., models sensitive to multiple substitutions at the same site and rate
heterogeneity across the phylogeny. And finally, stripping the alignment of its most
rapidly evolving sites and using only the remaining more slowly evolving sites to
reconstruct phylogenies reduces the amount of LBA noise in the dataset [29]. These
approaches can be used in combination. While databases such as Peroxibase [30] house
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all the up-to-date peroxidase sequences [31], we have included only those MHPs from
completed mammalian genomes (allows us identify species-specific gene birth and
death). We have used Maximum Likelihood (ML) and Bayesian methods of phylogeny
reconstruction together with the stripping of the most rapidly evolving sites in the
dataset.
The major questions addressed in this study pertain firstly to the resolution of the
evolutionary relationships of these MHPs using molecular sequence data, and secondly,
to the analysis of functional diversities among these superfamilies using the resolved
phylogeny and ML methods for testing selective pressures.
Selection can be classified as being neutral, purifying or positive. Positive
selection/Adaptive evolution is strongly indicative of functional shifts within proteins
[32]. To determine what selective pressures may have influenced the functional
diversification of the MHP families, we tested the data using a variety of ML models of
evolution with different properties. These included models that allow for only purifying
selection and/or neutral evolution, and those that allow for positive selection. Likelihood
scores for all alternative models and their null hypotheses are calculated. The likelihood
scores for the null hypothesis versus the alternative hypothesis for those models that are
extensions of each other were then compared using a likelihood ratio test (LRT) for
goodness-of-fit. For those models that allow for the estimation of site-specific evolution,
we can identify those amino acids that have undergone positive selection. The location of
these amino acid positions were estimated using Bayesian statistics and their location
and possible functional significance were determined. In our analysis we have shown





The MHP dataset for this study consisted of 31 single gene orthologues from MPO,
EPO, LPO, and TPO classes, totaling 1,017 aligned positions. The species phylogeny for
the mammals has previously been fully resolved [33]. In brief, the mammalian species
phylogeny describes Marsupialia (i.e. Opossum in our dataset) as outgroup to all other
mammals, followed by the divergence of the Carnivora (i.e. Dog in our dataset) and the
Cetacea (i.e. Cows in our dataset), and finally the emergence of the Euarchontoglires
clade (i.e. primates and rodents) [33], see Figure 1a. The ML phylogenetic tree was
estimated using MultiPhyl [34] and MrBayes 3.1.2 [35], the results were congruent, see
Figure 2a. Each of the four superfamilies branched into their respective functional
groups, with the members of the TPO superfamily taking the position of outgroup with
high support values. The topology shows MPO, EPO and LPO shared a most recent
common ancestor (MRCA) with a gene duplicate of TPO. The MPO and EPO groups
themselves shared a MRCA and functionally diverged following a further gene
duplication event. Therefore these two peroxidases (MPO & EPO) are the most closely
related of all the MHPs in this study.
Despite the 4 major clades in the phylogeny corresponding to the 4 major groups of
MHPs, the relationships of the species within these clades conflicts with the previously
published mammalian species phylogeny [33]. The rat and mouse are members of the
glires group, and as such are a sister group to the primates, which together form the
Euarchontoglires mammalian superorder. The topology seen here for the LPOs (see
Figure 2a) suggests that dog and cow are the outgroup to the primate clade. This is a
common error in mammalian phylogeny reconstruction, and has been proven to be an
effect of LBA [36]. Also, for the TPO group opossum is placed next to rat and mouse
and not as the outgroup as expected, suggesting that the opossum and the rodents have
similar rapid rates of evolution, see Figure 2a.
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We adapted the site stripping method using the slow-evolving positions for each species
in the MSA to reconstruct the phylogeny, while still retaining adequate amounts of signal
[29]. This approach is similar to the ‘Slow-Fast Method’ [37] and is therefore an
approximate method that removes noise from the data by removing those sites that are
most likely to contain homoplasy and focusing on the more evolutionary informative
positions for phylogeny reconstruction. Each site within the MSA was classified
according to rates of evolution (estimated using ML based on a fixed phylogenetic tree).
To determine what number of categories to remove, we progressively stripped each
category from the most rapidly evolving sites to the most slowly across the entire MSA.
We also combined removal of the fastest and slowest sites from the dataset in our
analysis, this was initially performed with the PXDN data included, see Figure 1b. Each
time a category was removed the phylogenetic tree was estimated from the remaining
MSA using ML. The ideal tree was created by pruning the mammalian supertree as
published by Murphy et al. [33] (with the inclusion of chicken) and is depicted in Figure
1a. The difference between each site-stripped phylogeny and the ideal phylogeny was
calculated using a nodal distance calculation RMSD [38], see Figure 1b. From Figure 1b,
it is seen that the removal of rapidly evolving sites gradually removes the noise from the
data and the remaining signal moves towards the canonical species phylogeny [33]. For
the dataset consisting of MHPs and PXDN sequences, the RMSD value reaches a
minimum at the removal of 4 site categories (8, 7, 6 and 5) leaving a MSA of length 850
sites (including gaps/missing data), see Figure 2b for resultant topology, after this point
the RMSD values rise, see Figure 1b. It is important to note that the slowest evolving
positions can be misleading particularly with excessive removal of sites, as the number
of characters for reconstruction will decrease with every cycle, therefore caution must be
taken in applying this method. This analysis was also performed on the dataset
containing only MHP sequences, and the RMSD value reaches a minimum at the
removal of 3 site categories (8,7, and 6) leaving a MSA of length 613 sites (including
gaps/missing data), see Figure 3a for resultant topology. The reduced MSA for MHP
data is given in Additional file 1 and the corresponding TOPD results are given in
Additional file 2. The nodal distance (RMSD) calculation is based entirely on the
branching pattern and hence does not account for evolutionary rate variation across the
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phylogeny. Using this site-stripped MSA the phylogeny was estimated using both
MrBayes and MultiPhyl methods, both of which produced identical phylogenies*. (*We
note here that the one exception, using the Bayesian reconstruction method, was the TPO
primate monophyly was not fully resolved in the TPO clade but instead supported a
human-chimp-macaque polytomy.)
All gene duplication events were verified using gene tree - species tree reconciliation.
We analysed the resolved MHP phylogeny (Figure 3a), and identified in total 4
duplication events and 4 losses. This method over prescribes gene losses as in the case of
EPO, where the sequence data was not available and therefore is assumed to be a loss.
There is an LPO specific duplication event predicted, see Figure 3b. Our results show
differential retention and loss in the LPO lineage following this gene duplication event
resulting in the cow species retaining an alternative duplicate copy to the other mammals
in the dataset, as shown in Figure 3b. This method must be used with caution as it does
not take into account rate heterogeneity amongst species or sites in the data, and relies
solely on the topology. However, reciprocal BLAST analysis of the cow sequence
against the other mammal genomes identifies this sequence as an ortholog.
Functional Diversity and Evolution of Specificity
We wished to test the hypothesis that following the gene duplication events in the MHPs
(as resolved in this study), selective forces - specifically positive selection - have
contributed to the observed changes in function in each of the 4 major groups of MHPs.
Tests for heterogeneous selective pressures were carried out on the resolved phylogeny
using the evolutionary models implemented in PAML 3.15 [39] and the complete MSA.
The Dn/Ds ratios were estimated in a likelihood framework at both site-specific and
lineage-specific levels. A total of seven tests of significance were carried out using χ2
tests of significance, five site-specific comparisons and two branch-site comparisons
were performed.
No positively selected sites were estimated for the one ratio model (see Additional file
3). Strong purifying selection across sites was indicated with an ω of 0.1516. However,
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this model is a poor fit for the data (lnL = -34417.1085). Positive selection was tested in
a site-specific manner across the dataset using the site models; M1 (neutral), M2
(selection), M3 discrete (k = 2), M3 discrete (k = 3), M7 (beta), M8 (beta & omega > 1)
and M8a (beta & omega = 1). The results of the site-specific analysis are shown in
Additional file 3.
Poor likelihood values were achieved using the site-specific models of evolution,
however, the most complex site-specific model used, M8 yielded significant results when
it was tested with its null model M8a. A small proportion of sites are under relaxed
positive selection (Additional file 3). Through the use of Bayesian estimations, four
positively selected sites have been identified across the alignment, with posterior
probability (PP) > 0.50.
Results of the branch-site model B with each of the families individually labeled as
foreground are shown here in Table 3; see Figure 3a for corresponding foreground
branches. (Results for model A are given in Additional files 4 and 5). To determine
whether there is rate heterogeneity along different branches in the phylogeny, we
compared models allowing for only site-specific evolution with those allowing for
branch-site specific evolution (i.e. M3 K = 2 with Model B and M1 with Model A).
Following LRT analysis it was found that both models A and B were significant
following χ2 test with two degrees of freedom. The likelihood score from model B for
each family had improved significantly from those obtained using model A, as a result,
model B was determined as the best fit model in each case tested and these results are
summarized in Table 3. Positively selected sites identified with model B were estimated
using the Naïve Empirical Bayes (NEB) method [40]. The results of which are discussed
now in detail.
Our results show that following gene duplication, each individual type of MHP has
undergone positive selection in amino acid residues that are unique to that type of MHP,
see Table 3. As positive selection is closely associated with functional shift, we postulate
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that these positively selected sites have significantly contributed to the evolution of the
functional diversity of these MHPs.
For the MPO superfamily, a total of 19 positively selected sites were identified (PP >
0.50). We have found functional information from the literature on 11 of these sites,
these are now discussed: Position 80 (Arg) is located within the propeptide sequence and
is under positive selection. Previous studies indicate that propeptide in MPO plays a key
role in the processing and sorting of human MPO [41]. Position 568 is under positive
selection and is next to the polymorphic site R569W, mutations in position 569 have
been shown to suppress posttranslational processing in MPO [42]. The 2 positions with
strongest support, PP > 0.95, are separated by 8 amino acid residues on the MPO heavy
chain, they are Asn496 and Leu504. These 2 positions along with Tyr500 are in close
proximity to the proximal heme ligand in MPO, His502 [3]. Position 259 (Leu) is located
between two important distal residues, Gln257 and His261, involved in the formation of
hydrogen bonds [3]. His261 has an important role in the formation of compound I, a
redox intermediate of the peroxidase cycle [2]. A further four sites (Leu630, Gln633,
Glu652; (primates Lys652) and Asn654 (primates Lys654) were identified as positively
selected, PP > 0.70, these are located within a disulfide bond linking helices 19 and 22
on the MPO heavy chain. Disulfide bonds are associated with the folding and stability of
proteins and as such are significant to the overall function of that protein [43].
For the EPO clade, 28 sites are positively selected, PP > 0.50. We have found functional
information for 15 of these sites. One of these, Asp71, is located in the EPO propeptide.
The inferred phylogeny, shown in Figure 3a, suggests that MPO and EPO are closely
related enzymes, therefore it may be possible that the EPO propeptide may also be
crucial for the function of EPO. The region separating the catalytic residues Arg377 and
His474 [3], contains 8 positively selected sites (PP > 0.50). Arg377 is the conserved
prominent distal amino acid associated with hydrogen bond formation. The proximal
heme ligands His474 (EPO), His502 (MPO) and His468 (LPO), are conserved in all the
MHPs [3] [25]. Six of the 28 positively selected sites, Arg584, Gln588, Arg591, Ala618,
Gly626 and Ala627, are located on the EPO heavy chain within a single disulfide bond
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region, this would suggest that they are structurally and functionally important to EPO.
Position 441 has been identified as under positive selection, this residue has also been
noted as being polymorphic in the human population (Lys/Thr).
There are 18 positively selected sites for the LPO group (PP > 0.95). We have found
functional information on 13 of these sites. Residues Glu72, Asn87 and Trp91 are found
in the LPO propeptide sequence and have a probability of greater than 0.95 of being
positively selected. Residues Asn255, Phe282, Ser312, Ser352 and Glu355 are all
located in the disulfide bond region (PP > 0.95). From biochemical analysis both Arg372
(Arg377 in EPO) and His468 are believed to have catalytic properties, and are conserved
in the MHPs [3] [25]. We find positive selection in His376 (PP > 0.99) just four amino
acids downstream of the first of these catalytic residues (Arg372), interestingly this site
is specific to the primate lineage. Also we have detected positive selection in Glu470 (PP
> 0.98) adjacent to the second catalytic site (His468). We have also detected positive
selection in Asp700 which is a known genetic variant and Glu240 and Gln245 that are
located to the right and left of a known human polymorphism A244T.
With the TPO clade treated as foreground, 8 sites are positively selected, PP > 0.95. Of
these 8 sites, 6 are missing in the alternatively spliced TPO isoform 5, which exhibits
incorrect protein folding [44]. Asp228 (PP > 0.95), Ala232 and Ala242 (both PP > 0.50)
are in the region of the TPO active site His239. Glu378 has also been identified as a
novel mutational site (E378K) associated with the common inherited deficiency total
iodide organification defect (TIOD) and is under positive selection in our analysis [45].
Independent analysis for positive selection using DIVERGE [46] software further
supports our findings, see Table 4 for summary of results. Values greater than zero for
the coefficient of functional divergence, θ, indicate a functional shift between clusters.
Rate heterogeneity among sites varies with respect to the gamma distribution (α). We
estimated θ for each of the four MHP clusters. This analysis shows significant functional
constraints among the four MHP clades, with the null hypothesis θ = 0 being rejected for
all clusters analysed. The analysis of closely related MPO and EPO clusters result in the
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lowest θ value (0.2833 +/-0.0837), and both have microbicidal activity (Table 1). θ
increases at least 1.5 fold for the more distantly related/functionally divergent clusters.
These results provide statistical evidence of the diverse functions of these MHP
enzymes.
We further test the relationship between positive/directional selection and functional
shift by analyzing the effect of these substitutions on the MPO 3D structure, see Figure
4. Modeling the MPO human sequence using SwissModel and using the mutate tool in
DeepView v3.7, we have performed in silico site directed mutagenesis on those sites
identified in our study as being positively selected [47] [48]. The structure with
positively selected sites and the heme binding site is shown in Figure 4a. We find that
mutating these positions from their positively selected state to the ancestral state causes a
variety of effects on the hydrogen bond formation within the 3D structure, see Table 5
for a summary of the effects on hydrogen bonds. Hydrogen bonds play an important role
in maintaining the structural integrity of a protein, any disruption of such forces is likely
to upset the balance between the structural and functional dynamics [49]. On mutating
each of these 19 positively selected amino acids we find that 4 bonds are lost and 4 are
independently gained in the protein, for summary see Table 5. For the mutations: N496F,
Y500F, and L504T, the positions of the losses and gains of hydrogen bonds are
significant as these amino acid are in close proximity to the proximal heme ligand
His502, shown in Figure 4a. The mutation from leucine to threonine at position 504
results in the formation of an additional hydrogen bond between Gly501 and Leu504.
Gly501 is directly bound to the proximal heme ligand. In addition, the N496F mutation
illustrated in Figure 4b, results in the loss of the hydrogen bond with Asn587. The
Asn587 and His502 are connected by a hydrogen bond [3]. The loss of the hydrogen
bond, as a result of the mutation at position 496, is likely to affect the structural integrity
of the link between Asn587 and His502. Disruption to the hydrogen bonds in this
catalytically important region may have direct implications for functional divergence of
the MPO enzyme. The A471R mutation results in an increase in the number of hydrogen
bonds associated with this position. This position is upstream from Asn483 which is
thought to be responsible for MPOs dimer interaction [3]. The mutation from cysteine to
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serine at position 316 results in the formation of a hydrogen bond with Gln329 and the
loss of one of the bonds to Asp593, see Table 5. Cys316 is next to the single disulphide
bridge (Cys319) that connects MPOs symmetry-related halves [3]. The C316S mutation
may potentially disrupt this disulphide bridge.
Discussion and Conclusions:
The MHPs are a functionally diverse family of enzymes which are implicated in a variety
of inflammatory and neurodegenerative diseases such as asthma and AD respectively. In
this study the evolutionary history of the four major groups of MHPs; MPO, EPO, LPO
and TPO, was investigated allowing for the analysis of their functional diversity.
Initial ML and Bayesian phylogenies estimated here for the MHPs support previous
biochemical studies [3] [8] [9]. From Figure 3 the order of gene duplication events can
be traced, with an MPO-EPO-LPO MRCA arising from a gene duplication with extant
TPO; then a further duplication event that gave rise to, (i) the MPO-EPO MRCA, and
(ii), the lineage leading to extant LPO; and the final and most recent duplication of the
MPO-EPO MRCA into extant MPO and EPO clades. PXDN is the outgroup to the MHP
sequences and was included in the analysis to illustrate that TPO is the most ancestral
MHP (Figure 2a). However, the species relationships estimated within these clearly
defined clades were in disagreement with the previously resolved mammalian phylogeny
[33].
Including all sites of the alignment in the analysis, we have shown that the major types of
MHP form monophyletic clades and are therefore the result of gene duplication events
prior to speciation of modern day mammals, see Figure 2(a). However, also evident from
Figure 2(a), species with more similar generation times are clustered together, with
species of shorter generation times and therefore more rapid rates of mutation assuming a
basal position in the phylogeny. This observed branching pattern could be a result of
LBA, incorrect ortholog prediction or hidden paralogy.
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If a phylogeny is seen to approach the ideal by removing the most rapidly evolving sites,
then we propose that LBA is most likely to have contributed to the misleading
phylogeny. To test for the presence of LBA we calculated 8 categories of rates of
evolution for all sites, from the most rapidly evolving to the most slowly evolving. We
observed that the sequential removal of rapidly evolving categories of sites from the
alignment decreased the difference, in terms of nodal distance RMSD, between the
phylogeny produced and the ideal phylogeny. This occurred only for removal of the 4
fastest evolving categories of site from the alignment. Further removal after this point
resulted in increased RMSD values between the phylogeny produced and the ideal. The
MHP phylogeny shown in Figure 3(a), with maximum number of sites and minimum
amount of noise. We propose that a possible reason for the presence of LBA in this
dataset is the presence of taxa with vastly different generation times. The rodentia have
previously been shown as “fast evolving” due to their short germ-line generation time,
whereas species such as dogs and humans have longer germ-line generation times [27]
[28] [50]. In any given dataset there are sites that are variable and sites that are
invariable, this pattern is conserved across homologous sequences. In a dataset with a
mixture of germ line generation times, the mutation rate in the species with shorter germ
line generation times will be higher, because the number of cell divisions per unit time is
greater. Therefore the number of mutations in the variable regions will increase for these
species. The result is an LBA effect derived from having a mixture of long and short
germ line generation times in the dataset, where the species with a short germ line
generation time assumes a basal position in the phylogeny [26] [27] [28]. A number of
approaches have been explored to systematically deal with fast evolving taxa the most
popular include, (1) reconstructing the phylogeny based on slow evolving sites (applied
here), (2) increasing the sample size, this is based on the assumption that increasing the
sample size actually increases the number of slowly evolving positions, (3) decreasing
the distance to the outgroup, and (4) using more accurate models of sequence change
such as covarion derivatives.
Our gene tree - species tree reconciliation analysis has verified the duplication pattern
amongst the MHPs. However, we believe that current methods of reconciliation such as
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the one used here may be biased towards inferring excess gene duplication and
differential loss events, as is the case here. The method only considers the topology and
not the corresponding alignment or any rate heterogeneity that may exist [51]. We would
also like to highlight that the variation of the “Slow-Fast” method employed here is an
approximate method for a complex evolutionary dynamic and is not without its
limitations.
Using this fully resolved phylogeny, positively selected sites have been identified,
through the use of Bayesian estimation, unique to all four MHPs; MPO, EPO, LPO and
TPO. The majority of these sites are in close proximity to catalytically important
residues, suggesting that they may potentially be linked to functional shifts across the
MHPs. The conserved proximal histidines in close proximity to sites under positive
selection in MPO, EPO and LPO are crucial in preserving the redox properties of the
heme iron for catalysis [3]. The conserved distal histidines, also shown here to be in the
vicinity of positively selected sites, act as both proton acceptors and donor to oxygen
during the formation of Compound 1, which is an integral step in the peroxidase pathway
[3]. A number sites identified under positive selection are located in disulphide bond
regions, which are believed to be crucial to the structure and function of a protein.
Disruption of such regions can be detrimental to the enzymatic stability and activity [43]
[52]. In particular, six sites pertaining to the LPO family are linked to the same
disulphide bond. This strongly suggests that these sites are associated with the unique
function of LPO as they are not present in the two closely related families MPO and
EPO. In the TPO analysis the majority of the sites with highest probability of being
positively selected are located in exon 8 of the protein. Deletion of exon 8 results in
misfolding of the TPO protein [44]. Exon 8 is also believed to be part of TPOs catalytic
centre (exons 8, 9 and 10) [53]. TPO functional defects are strongly associated with
TIOD and several deleterious mutations within this catalytic region have been reported
[44] [53] [54] [55]. We also find that one of our positively selected sites in TPO is
associated directly with an inherited deficiency disorder [55].
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Our detailed in silico site directed mutagenesis of the positively selected sites in MPO
has shown that mutating these positions from their positively selected amino acid state to
an alternative ancestral state results in loss/gain of hydrogen bonds between alternative
amino acid positions for other sites in particular in the heme binding region of the MPO
structure. The sites we have identified as positively selected in the MHPs have played a
major role in the functioning of these enzymes as evidenced by mutational studies,
proximity to active sites and catalytic residues, and inherited disorders.
The results of this study show for the first time from molecular sequence data (i) how
this medically important group of enzymes are related to each other, and (ii) suggest that





Protein coding sequences for MHPs were retrieved from the Ensembl database for all
available completed mammalian genomes using the pre-defined orthologues identified in
Ensembl [56]. The mammalian genomes and the corresponding genome versions used
for each of the major families in our dataset were as follows: Homo sapiens v42.36d;
Pan troglodytes v42.21a; Macaca mulatta v42.10b; Mus musculus v42.36c; Rattus
norvegicus v42.34l; Canis familiaris v42.2; Bos taurus v42.2e (no EPO sequence
available), and, Monodelphis domestica v42.36c. Ensembl identifies orthologues by
performing a genome-wide reciprocal WUBlastp+SmithWaterman search of each gene
across all completed genomes. Multiple sequence alignment (MSA) is then performed
using the MUSCLE software [57] and the best reciprocal hits following the sequence
similarity search. The longest alternative transcript in each case was used. These
sequences were combined into a single MHP dataset of 31 sequences. Two amino acid
sequences representing the peroxidasin (PXDN) family, from the Pan troglodytes and
the Gallus gallus genomes, were retrieved from the PeroxiBase database [31]. The
sequence data are given in Table 2.
Multiple Sequence Alignment
Each protein coding sequence in the MHP dataset was translated to amino acid using in-
house translation software. This protein sequence dataset and the two PXDN sequences
were combined to give a dataset of 33 sequences (complete dataset). Both MHP and
“complete” datasets were aligned in ClustalW 1.8 [58] independently using default
parameter settings. The corresponding nucleotide sequences for the MHP dataset were
aligned with respect to the amino acid MSA with the use of in-house software to insert
gaps in the protein coding sequence according to their positions in the amino acid
alignment. The nucleotide and subsequent protein MSAs were manually edited by
removing ambiguous regions from the alignment using the sequence alignment editor,
Se-Al 2.0a11 [59]. The PXDN sequences served as an outgroup for the MHPs and
therefore aided in determining the earliest diverging MHP.
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Site Stripping and Phylogeny Reconstruction
The phylogenetic tree for the dataset was estimated using Bayesian statistics
implemented in MrBayes 3.1.2 [35]. The model of amino acid substitution used was JTT
[60] because following model testing using MultiPhyl [34] this was the model that was
best-fit to the data. Using 4 Markov chains for 400,000 generations, trees were sampled
every 10 generations with the first 20,000 sampled trees discarded as burnin. The
remaining trees samples were summarized on a majority rule consensus tree with clade
supports given as Posterior Probabilities (PPs). ML trees were also inferred using the
high-throughput phylogenomics webserver, MultiPhyl [34]. The ML tree was generated
using the nearest neighbour interchange (NNI) tree search algorithm and 100 bootstrap
replicates implemented in MultiPhyl [34] under the Akaike Information Criterion (AIC)
statistic, the selected substitution model was JTT with invariable sites and a discrete
gamma model of rate heterogeneity. This was repeated a total of 10 times to generate
1000 bootstrap replicates. (The Bayesian tree reconstruction methods were applied to the
MHP dataset only).
The resulting phylogenies from both analyses (MrBayes and MultiPhyl) were then
analysed for signatures of LBA. The rate of evolution at each site in the alignment was
placed into one of 8 categories, 8 being the most rapidly evolving and 1 being the most
conserved, using the maximum likelihood approach implemented in TreePuzzle 5.1 [61].
Sites were progressively removed from the protein MSA according to their evolutionary
rate and the resultant trees were analysed for changes in topology.
Nine separate site-stripped alignments were constructed by successive removal of the
most rapidly evolving sites [29]. The aforementioned Bayesian method was used to infer
phylogenetic relationships for each of the nine alignments generated. The ML phylogeny
was also estimated for each of the site-stripped alignments from the model of best-fit




The pruned nodal distance method implemented in TOPD/FMTS v3.3 [38] was used to
calculate the distance between each of the site-stripped trees and the ideal tree. The ideal
tree was generated by pruning the resolved mammalian phylogeny [33] to represent
those taxa present. A distance matrix is calculated for both the site-stripped phylogeny
and the ideal phylogeny by counting the number of nodes that separate every taxon from
every other taxon on the tree. Using the root means squared deviation (RMSD)
implemented in the TOPD/FMTS v3.3 [38] software package, the RMSD between the
site-stripped phylogeny matrix and the ideal phylogeny matrix is calculated. A RMSD
value of zero indicates that the two trees being compared are identical.
Gene Tree - Species Tree Reconciliation
Following nodal distance analysis, the gene phylogeny with the lowest RMSD value (for
the MHP sequences alone), and the species tree were examined for gene duplication and
loss events using the default settings for gene tree - species tree reconciliation
implemented in GeneTree 1.3.0 [62].
Selective Pressure Analysis
Analysis of variation in selective pressure following gene duplication in the MHPs was
carried out using codon substitution models implemented in PAML 3.15 [39]. Both site-
specific and branch-site specific models were applied. The models used for this analysis
allow for heterogeneous nonsynonymous-to-synonymous rate ratios (ω = Dn/Ds) across
sites and amongst branches/lineages.
An ω-value > 1 indicates positive selection, ω < 1, purifying selection and neutral
evolution when ω = 1. The statistically significant model for the data was selected using
a series of LRTs to compare models and their more parameter rich extensions. Tests of
significance were carried out using χ2 tests of significance, the comparisons performed
were; M0 (one ratio) with M3(k = 2)(discrete), M1(neutral) with M2(selection), M3(k =
2) with M3(k = 3) discrete models, M7 (beta) with M8 (beta & omega > 1), M8 (beta &
omega > 1) with the null hypothesis M8a (beta & omega = 1), M1 with model A
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(branch-site) and finally M3(k = 2) with model B (branch-site). The models and
approach taken here have been described previously [39] [63].
The probability (PP) of a specific amino acid site belonging to the positively selected
category is estimated using the empirical Bayes method for each superfamily
individually [40] [64] [65].
Functional Divergence analysis
Using the MHP gene phylogeny with the lowest RMSD value, each of the four MHPs
were selected as independent clusters. Using the MHP protein MSA and this MHP gene
phylogeny, statistical analysis implemented in the software DIVERGE v 1.04 [66] [46],
was used to estimate the coefficient of functional divergence (theta ML or θ) for all pairs
of clusters. The following are the clusters used in the analysis are taken from the
resolved phylogeny (from Figure 3a) (1) MPO Cluster, (2) EPO Cluster, (3) LPO
Cluster, and (4) TPO Cluster.
3D Modeling and In Silico Mutational Analysis
Homology modeling was performed using the human representative sequence for the
MPO family and the first approach mode implemented by the homology-modeling
server, SWISS-MODEL [48]. The structure was modeled using the crystal structure of
bromide-bound human MPO isoform C (PDB accession code 1d2vC). The positively
selected sites identified from the PAML 3.15 (Yang 1997) analysis were highlighted (in
gold) on the 3D structure generated using DeepView v3.7 [47]. The conserved proximal
heme ligand (His 502) was also highlighted (in blue) on the 3D model. In silico
mutational analysis on these positively sites was carried out and their subsequent affect
on hydrogen bonding was assessed using DeepView v3.7 [47].
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Figure 1: The distance between each of the site stripped phylogenies and the ideal
mammalian peroxidase phylogeny.
(a) The ideal phylogeny pruned from the mammalian phylogeny by Murphy et al.
(2001), the peroxidasin sequences are outgroups to the MHP clade. The following are the
species abbreviations used: Dog (D); Cow (C); Macaque (Ma); Human (H); Chimp (Ch);
Rat (R); Mouse (M), Chicken (G), and Opossum (Op). This phylogeny was compared to
each of the resultant site stripped phylogenies. (b) Graph showing the RMSD nodal
distance (y-axis) between each site-stripped phylogeny (x-axis) and the ideal phylogeny.
On the X axis: All: refers to the complete MSA; 8: site category 8 removed from the
MSA; 8, 7: categories 8 and 7 removed from the MSA and so on up to the final column
that contains only the most slowly evolving category of site. Values close to/zero
correspond to complete agreement between the ideal and site stripped phylogeny.
Figure 2: Phylogeny of the mammalian heme peroxidases before treatment for long
branch attraction and after treatment.
(a) Initial unresolved ML tree for mammalian heme peroxidases and peroxidasin from
Pan troglodytes and Gallus gallus from the entire dataset. The bootstrap support values
from 1000 replicates are shown on all nodes. (b) Resolved phylogeny following site
stripping, the cow sequence for LPO can be seen to take an unusual place on the
phylogeny.
Figure 3: Fully resolved mammalian heme peroxidase phylogeny with duplication
and loss events depicted.
(a) Resolved ML tree for mammalian heme peroxidases. The bootstrap support values
from 1000 replicates are shown on all nodes. The TPO primate clade appears here as a
polytomy as the branch lengths are extremely short, however, this is in fact resolved with
a low Bootstrap of 56%. The star symbol denotes those branches that were treated as
foreground in the selection analysis. (b) The analysis of the resolved phylogeny using
gene tree species tree reconciliation method implemented in GeneTree. The large filled
circles represent gene duplication events, and the red branches indicate gene losses.
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Figure 4: Location of positively selected sites in the MPO structure and their effect
on bonding within the structure.
(a) 3-D structure of the human MPO sequence, highlighted in gold are those sites that are
positively selected in MPO, in blue is the heme binding site. (b) Example of the affect on
hydrogen bonding of one such mutation at positively selected position 496 in human
MPO from Asparagine to Phenylalanine.
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Table 1: Mammalian heme peroxidase features and functions (adapted from Clark






Tissue Expression Biological Function
MPO (1.11.1.7) 17 Neutrophils, mono-
nuclear phagocytes
Microbicidal activity
EPO (1.11.1.7) 17 Eosinophils Microbicidal activity








MPO = Myeloperoxidase; EPO = Eosinophil peroxidase; LPO = Lactoperoxidase; TPO
= Thyroid peroxidase.
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Table 2: Representative mammalian heme peroxidase sequences used in this study.
Superfamily Species Entry ID (Name)*/Gene ID Length (aa)
MPO Homo sapiens ENSG00000005381 778
Pan troglodytes ENSPTRG00000009449 778
Macaca mulatta ENSMMUG00000002266 777
Mus musculus ENSMUSG00000009350 719
Rattus norvegicus ENSRNOG00000008310 719
Canis familiaris ENSCAFG00000017474 743
Bos taurus ENSBTAG00000012783 596
Monodelphis domestica ENSMODG00000014737 403
EPO Homo sapiens ENSG00000121053 716
Pan troglodytes ENSPTRG00000009446 716
Macaca mulatta ENSMMUG00000011973 717
Mus musculus ENSMUSG00000052234 717
Rattus norvegicus ENSRNOG00000008707 716
Canis familiaris ENSCAFG00000017456 752
Monodelphis domestica ENSMODG00000014755 725
LPO Homo sapiens ENSG00000167419 713
Pan troglodytes ENSPTRG00000009448 712
Macaca mulatta ENSMMUG00000002264 716
Mus musculus ENSMUSG00000009356 711
Rattus norvegicus ENSRNOG00000008422 710
Canis familiaris ENSCAFG00000024533 719
Bos taurus ENSBTAG00000012780 713
Monodelphis domestica ENSMODG00000014744 719
TPO Homo sapiens ENSG00000115705 934
Pan troglodytes ENSPTRG00000011610 857
Macaca mulatta ENSMMUG00000009662 839
Mus musculus ENSMUSG00000020673 915
Rattus norvegicus ENSRNOG00000004646 915
Canis familiaris ENSCAFG00000003217 932
Bos taurus ENSBTAG00000002567 869
Monodelphis domestica ENSMODG00000014296 872
PXDN Pan troglodytes 5828 (PtroPxd01)* 1463
Gallus gallus 4049 (GgaPxd01)* 1447
Note: * - Assigned entry ID and Name in the PeroxiBase database
The common names for the genomes used are; Homo sapiens: human, Pan troglodytes:
chimp, Macaca mulatta: macaque, Mus musculus: mouse, Rattus norvegicus: rat, Canis
familiaris: dog, Bos taurus: cow, Monodelphis domestica: opossum, Gallus gallus:
chicken. aa: amino acid.
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Table 3: Parameter estimates and likelihood scores for branch-site model, model B.
Model P L Estimates of parameters Positively
selected sites
MPO
Model B 5 -33655.0405 p0= 0.4975, p1= 0.4553, (p2= 0.0246, p3= 0.0225)
Background:
ω0= 0.0458, ω1= 0.3307, ω2= 0.0458, ω3= 0.3307
Foreground:







Model B 5 -33647.5634 p0= 0.4967 p1= 0.4469, (p2= 0.0297, p3= 0.0267)
Background:
ω0= 0.0464, ω1= 0.3322, ω2= 0.0464, ω3= 0.3322
Foreground:







Model B 5 -33627.3508 p0= 0.4431, p1= 0.3884, (p2= 0.0898, p3= 0.0787)
Background:
ω0= 0.0470, ω1= 0.3414, ω2= 0.0470, ω3= 0.3414
Foreground:







Model B 5 -33639.5793 p0= 0.4358, p1= 0.3690, (p2= 0.1057, p3= 0.0895)
Background:
ω0= 0.0479, ω1= 0.3468, ω2= 0.0479, ω3= 0.3468
Foreground:





Model B allows each foreground lineage to be tested independently of all other lineages,
hence the four clusters (MPO, EPO, LPO, TPO - each in turn treated as foreground), and
estimates 5 parameters (P) in total. p0,p1, p2 and p3 are proportions of sites in the dataset
with the corresponding ω value, i.e, ω0, ω1, ω2 and ω3 for the foreground and the
background lineages independently. The final column gives the estimated number of
sites with posterior probabilities of greater than 0.50 of belonging to the positively
selected category. Note: NEB: Naïve Empirical Bayes analysis.
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Table 4: Summary of results of analysis using DIVERGE software.
MPO/EPO MPO/LPO MPO/TPO EPO/LPO EPO/TPO LPO/TPO
θ ML 0.2832 0.4504 0.4984 0.4552 0.4304 0.4280
SE θ 0.0837 0.0744 0.0783 0.1021 0.0950 0.0756
LRT θ 11.4512 36.6860 40.4815 19.8713 20.5223 32.0448
α ML 0.3034 0.4221 0.4172 0.4863 0.4654 0.5413
Each cluster analysed is shown in the columns of the table. θ ML: Coefficient of
functional divergence. SE θ: Standard error of the estimate Theta. LRT θ: 2 log-
likelihood-ratio against the null hypothesis of θ = 0. α ML: Gamma shape parameter for
rate variation among sites.
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Table 5: Summary of results from SwissModel analysis of positively selected sites.

















Mutation from positively selected site in MPO (using human model) to the amino acid
present in EPO, LPO and TPO at that position (in cases where there was conflict the
majority rule consensus at that position was taken). Posterior Probability values extracted
using NEB analysis in model B Codeml. Effect on H-Bonds is classified as “+” if an
increase in the number of bonds with positively selected amino acid, “-” if a hydrogen
bond or a number of hydrogen bonds were lost with the positively selected site, and “=”





Title: The resultant site stripped multiple sequence alignment of MHP sequences.
Description: This figure depicts the multiple sequence alignment that was selected
following RMSD analysis. This alignment has sites of rate category 8, 7, and 6 removed.
Additional file 2
File format: DOC
Title: RMSD nodal distance between each site-stripped MHP phylogeny and the
ideal phylogeny.
Description: This table summarizes the results of the statistical comparison (RMSD) of
the ideal phylogeny with each site stripped phylogeny. Values closer to zero are closer to
complete agreement, the alignment with site categories 8 through to 6 removed, is the
phylogeny closest to ideal.
Additional file 3
File format: DOC
Title: Parameter estimates and likelihood scores of one ratio and site-specific
models.
Description: The data presented in this table are the results of ML analysis of site
specific evolutionary models applied to the MHP alignment. The name of the model is
given in column 1, the number of parameters estimated is given in column 2, the Log
likelihood value in column 3, and the parameter estimates in column 4 and 5.
Additional file 4
File format: DOC
Title: Parameter estimates and likelihood scores for branch-site models: MPO and
EPO clades.
Description: This table summarizes the results of ML analysis on the MHP data, using
branch specific models of evolution. The MPO and EPO clades are treated as foreground
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lineages independently and all other peroxidase clades as background. The LRTs are
performed between model A and M1 and model B and M3K2 from Additional file 3.
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Title: Parameter estimates and likelihood scores for branch-site models: LPO and
TPO clades.
Description: This table summarizes the results of ML analysis on the MHP data, using
branch specific models of evolution. The LPO and TPO clades are treated as foreground
lineages independently and all other peroxidase clades as background. The LRTs are
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